Stimulated platelets, in the presence or absence of aspirin, synthesize significant quantities of 12-hydroxyeicosatetraenoic acid (12-HETE), which is chemotactic and chemokinetic, and enhances mononuclear cell procoagulant activity. During a cell-cell interaction between stimulated platelets and unstimulated neutrophils, platelet 12-HETE is metabolized to 12,20-dihydroxyeicosatetraenoic acid (12,20-DiHETE) by neutrophils. Characteristics of the enzyme system in unstimulated neutrophils responsible for this omega-hydroxylation were investigated. A broad range of cytochrome P-450 inhibitors, as well as leukotriene B4, blocked formation of 12,20-DiHETE. Owing largely to released proteases, neutrophil homogenization abolished activity. Pretreatment with diisopropylfluorophosphate preserved activity in neutrophil homogenates. omega-Hydroxylation of 12-HETE was confined solely to the microsomal fraction. Specific activity increased 6.6-fold compared with neutrophil sonicates. The electron donor NADPH was a required cofactor. These results indicate that the enzyme in unstimulated human neutrophils, which metabolizes 12-HETE from stimulated platelets to 12,20-DiHETE in this cell-cell interaction, is a cytochrome P-450 monooxygenase.
pirin ingestion (1) . Recently it was demonstrated in animal models that glomerular immune injury is accompanied by increased 12-HETE synthesis (2) and that 12-HETE enhances epidermal cell proliferation (3) . Additional autacoid functions of 12-HETE include chemotaxis for human neutrophils in vitro (4) and in vivo (5) , chemokinesis for smooth muscle cells (6) , and enhancement of mononuclear procoagulant activity (7) . Because stimulated platelets synthesize in significant quantities, it is important to determine mechanism(s) of its further metabolism, and whether it interacts with other cells.
We have previously established that neutrophils can metabolize platelet 12-HETE in vitro by two different mechanisms (8, 9) . Stimulated neutrophils, in which the 5-lipoxygenase has been activated, convert platelet 12-HETE to 5S, 12S-dihydroxy-6-trans,8-cis,10-trans,14-cis-eicosatetraenoic acid (5S,12S-Di-HETE) (8, 10) . In contrast, unstimulated neutrophils metabolize platelet 12-HETE to (12S)-12,20-dihydroxy-5,8,10,14-eicosatetraenoic acid (12, ( 9, 1 1). The mechanisms underlying this neutrophil w-hydroxylation of platelet 12-HETE have not been studied.
In many cells and tissues, w-oxidation of eicosanoids is carried out by cytochrome P450 enzyme systems such as the one recently described for leukotriene B4 in neutrophils (12) (13) (14) (15) (16) . We have investigated whether such an enzyme might be operative in the setting ofa cell-cell interaction involving an unstimulated neutrophil and 12-HETE-the product of an activated platelet. We report here, on the basis of inhibition studies, NADPH dependence, and subcellular membrane localization, that the enzyme in unstimulated human neutrophils that w-hydroxylates released platelet 12-HETE is of the cytochrome P-450 type.
Methods
Preparation ofneutrophil suspensions. Cell suspensions containing 95% neutrophils (5% eosinophils) were prepared from 240 ml ofwhole blood collected by free flow in plastic tubing through a 16-gauge needle (17) . The blood was initially centrifuged at 200 g and platelet-rich plasma was removed. Remaining leukocytes and erythrocytes were suspended in Dextran T500 (1.5%). Leukocyte-rich plasma was removed and centrifuged at 280 g (10 min, 4C), and the resulting pellets were suspended in cold saline. 15 ml of resuspended cells were layered on each of three 10-ml aliquots of Ficoll-Hypaque (d 1.077). After centrifugation at 350 g (30 min, 4°C), the interface was discarded and erythrocytes in each neutrophil pellet were lysed with 6 ml of distilled water (25 s) . Upon return to isotonicity with 2 ml of 3.5% NaCl, 10 ml of phosphate-buffered saline (pH 7.4) was added. The suspension was centrifuged at 280 g for 5 min (4°C), and the neutrophils were suspended in Hepes buffer (pH 7 .45) containing calcium and magnesium (8) . In experiments involving subcellular fractionation, the Hepes buffer was modified (no calcium, 2.5 mM magnesium). Trypan blue exclusion by the neutrophil preparations averaged 95%, and no platelets were seen on stained smears. After exposure of neutrophils to thrombin or ionophore, 12-HETE, the platelet-derived hydroxy acid could not be identified by high-performance Platelet 12-Hydroxyeicosatetraenoic Acid Metabolism by Unstimulated Neutrophils 179 liquid chromatography (HPLC), confirming the absence of platelet contamination (9) .
HPLCassayfor 12,20-DiHETE production by neutrophils. Volumes of 3 X 10' neutrophils or appropriate aliquots of subcellular fractions were adjusted to 1 ml with Hepes buffer. Samples were preincubated in polypropylene tubes for 1 min at 37VC with stirring. Inhibitors or NADPH, when used, were added during the preincubation period. Reactions were started with 4.4 AM 12-HETE (sodium salt) and terminated at 5 min by addition of 1.5 ml of acetone and by placement on ice. In experiments involving subcellular fractionation, the reaction time was increased to 15 or 30 min. In such instances, calcium, which had been eliminated from the buffer, was added to a final concentration of 1.29 mM at the start of preincubation. Intact cells or cell fractions could be assayed without loss of activity after storage at 4VC overnight.
Precipitated protein was removed by centrifugation at 1,400 g for 15 min at 250C, and acetone evaporated from supernatants under nitrogen at 370C. After acidification to pH 4.0 with I N H3PO4, extraction three times with l-ml aliquots ofethyl acetate, and evaporation to dryness, residues were dissolved in 50 Ml of methanol/water (3:1). Tubes were vortexed and centrifuged for 5 min at 225 g, and 5 Ml of supernatant was injected into an HPLC column (9) . Reversed-phase HPLC was carried out on an 8-mm id. Radial-PAK C18 (10 Mm) column (Waters Associates, Milford, MA) with methanol/water/acetic acid (75:25:0.01), pH 6.1, as eluting solvent. Flow rate was 0.6 ml/min. Absorbance was monitored at 237 nm.
12,20-DiHETE and 12-HETE were quantified by comparison ofpeak areas with those of external standards of purified compounds. The 12-HETE standard was synthesized from ionophore-stimulated platelets. 12,20-DiHETE was prepared by incubation of purified 12-HETE with neutrophils or from thrombin-stimulated mixtures of platelets and neutrophils, as previously described (9) . Both compounds were purified by reversed-phase HPLC and quantitated spectrophotometrically using an extinction coefficient at 237 nm of 30,500 (18) .
For optimal results, assays for 12,20-DiHETE production by broken cell preparations or subcellular fractions were carried out in the presence of an NADPH-regenerating system, consisting of 0.02 M DL-isocitric acid (trisodium salt), 0.1 mg of isocitrate dehydrogenase/ml (grade 1, Boehringer Mannheim, Indianapolis, IN) and 1 mM NADPH (19) .
Inhibition of12,20-DiHETE production by neutrophil homogenates. Neutrophil homogenates derived from 0.9-1.2 X 10' cells were added to intact neutrophil controls (3 X I07 cells) at the start ofthe preincubation period and the assay for c-hydroxylation of 12-HETE performed as above. Reversal of the inhibitory effect of such homogenates by the elastase inhibitor a1-antitrypsin (Sigma Chemical Co., St. Louis, MO) was demonstrated by incubation of the homogenate with a,-antitrypsin for 1 h at 0°C prior to addition to intact neutrophils.
Inhibition of w-hydroxylation of 12-HETE by carbon monoxide. Neutrophils were treated with CO as described by Shak and Goldstein (20), using gas-saturated buffers (21) . Controls consisted of neutrophils exposed to nitrogen in the same manner. Hepes buffer was deaerated (vacuum pump) for 15 min and bubbled for 30 min with CO gas or nitrogen. Neutrophil stock suspensions were prepared by resuspension of pelleted neutrophils in the above CO, nitrogen, or air-equilibrated buffers, followed by overlaying with the respective gas. In these specific experiments, reactions were begun by addition of gas-equilibrated neutrophils to 12-HETE (sodium salt) which had been previously dissolved in air-equilibrated buffer. Contents ofreaction tubes were overlayed with appropriate gas and capped during incubation. An approximate CO to oxygen ratio of 11:1 was calculated from their solubility in water at 37°C (22) . Reoxygenation was accomplished by allowing the gas-equilibrated neutrophil stock solutions to remain uncapped under a hood. The neutrophils were then pelleted, the supernatants were discarded, and the cells were resuspended in air-equilibrated buffer.
Effect ofLTB4 on w-hydroxylation of12-HETE. LTB4 (Biomol, Philadelphia, PA) (0.22-4.4 MM, sodium salt) was added to 3 X 107 neutrophils during the preincubation period (15 1 1,000 rpm (10,000 g at center of tube) for 15 min (5°C). The resulting 10,000-g pellet was resuspended in 2 ml ofmodified Hepes buffer (containing 0.5 mM DTT) with a teflon pestle. The supernatant resulting from the 10,000-g centrifugation was further fractionated by ultracentrifugation at 35,000 rpm (100,000 g at center of tube) for 1 h (5°C). The 100,000-g supernatant was removed and the 100,000-g microsomal pellet was resuspended in 1.35 ml of modified Hepes buffer (0.5 mM DTT).
Carbon monoxide difference spectra. Spectral studies (21) were carried out in a Cary 118 double-beam spectrophotometer (Varian Associates, Palo Alto, CA). Sample and reference cuvettes contained 1 ml of microsomal suspension (1.45 mg of protein) or an identical quantity of granule protein. After the baseline was recorded, the sample cuvette was bubbled gently (3 min) with CO. Another baseline was then obtained to rule out hemoglobin contamination. The latter baseline was subsequently subtracted from succeeding spectra in order to obtain the curves presented in Fig. 6 . A CO (dithionite reduced vs. oxidized) difference spectrum was then produced by addition ofa few crystals ofthe reductant sodium dithionite to the sample cuvette. Finally, dithionite was added to the reference cuvette (untreated with CO) to reduce cytochrome b. The resulting difference spectrum of the reduced cytochrome P-450-CO complex was thereby obtained.
Other analyticalprocedures. Protein was measured by the technique ofLowry et al. (25) as modified by Miller (26) , with human serum albumin as standard (27) . Cell integrity was monitored by lactate dehydrogenase (LDH) assay (27) . The method of Wroblewski and LaDue (28), slightly modified, was employed using Sigma Chemical Co. reagents. One unit of activity equals a decrease in OD of 0.00 I/min. Cell supernatants for measurement of free LDH were prepared by centrifugation in a Beckman Instruments, Inc. microfuge for 3 min at 4°C. l-Glucuronidase was assayed essentially as previously described (27) terminated with acetone and precipitated protein was removed. Samples were acidified and lipids extracted with ethyl acetate. The lipids were redissolved in methanol/water (3:1) and injected into a reversed-phase HPLC column. Absorbance of effluents was monitored at 237 nm. The 12-HETE peak represents unconverted substrate remaining after the 5-min incubation period.
DiHETE in the presence ofknown cytochrome P450 inhibitors was compared with generation of 12,20-DiHETE in the absence of such inhibitors. Fig. 1 depicts results ofa control HPLC assay consisting of 3 X 107 unstimulated neutrophils incubated with 4.4 ,uM 12-HETE for 5 min. Under these experimental conditions, the quantity of 12,20-DiHETE recovered, calculated as a percentage of 12-HETE added to neutrophils, ranged from 24% to 46% in seven donors. When assays were repeated on separate occasions, differences between several individual donors appeared to be consistent. In multiple control assays the standard deviation of 12,20-DiHETE production averaged 4% of mean values. Enzyme activity in intact cells or fractions was stable upon storage at 4°C for at least 24 h.
Compounds that inhibited 12,20-DiHETE production by neutrophils are listed in Table I . Inhibitors of other oxidative processes, such as superoxide dismutase (SOD) and catalase, which had no effect on 12,20-DiHETE formation, are also shown. a-Naphthoflavone at 0.25 mM was a potent inhibitor of 12-HETE w-hydroxylation. Results of the HPLC assay in the presence ofthis inhibitor are shown in Fig. 2 . Absence ofreleased LDH in the cell supernatant demonstrated that the inhibitory effect observed with a-naphthoflavone was not due to neutrophil lysis. In addition, trypan blue exclusion indicated 96% viability after incubation of cells with 0.05 mM a-naphthoflavone. Furthermore, a-naphthoflavone inhibited w-hydroxylation of 12-HETE by isolated neutrophil microsomal fractions (see below). In two separate experiments with microsomal preparations, 0.05 mM a-naphthoflavone inhibited 12,20-DiHETE formation by 57% and 87%, respectively. Each of the cytochrome P-450 inhibitors studied interfered with 12,20-DiHETE production in concentrations generally used for this purpose (13, 29) . 5,8,11,14-eicosatetraynoic acid (ETYA), at a concentration of 0.03 mM, blocked 12,20-DiHETE formation by 62%. Inhibition of cytothrome P450 oxidase systems by ETYA has previously been reported (30) . w-Hydroxylation of 12-HETE by neutrophils was also inhibited 79% by 5 mM EDTA. This inhibition occurred despite addition of calcium to the assay system in quantities sufficient to compensate for the chelating effect of EDTA.
Carbon monoxide complexes with cytochrome P450 enzymes and is a potent reversible inhibitor. Treatment of intact neutrophil suspensions with a CO/02 mixture (1 1:1) resulted in almost total inhibition of 12,20-DiHETE production from 12- system (Table III) (Table III) .
N.ADPH dependence of neutrophil 12-HETE w-hydroxylation. Intact DFP-treated neutrophils were assayed for 12,20-DiHETE production in the presence ofan NADPH-regenerating system (isocitric acid, isocitrate dehydrogenase, and NADPH) (Table IV) . 12,20-DiHETE was measured 30 min after addition of 12-HETE to neutrophils. Presence of the NADPH regenerating system (or NADPH alone) did not result in an increase in 12,20-DiHETE formation by intact neutrophils. DFP-treated neutrophils were then sonicated (97% disruption) and centrifuged at 150 gfor 10 min (4°C). The supernatant was assayed in the presence and absence of the NADPH-regenerating system (Table IV) . In the absence ofadded NADPH, 12-HETE co-hydroxylation by the sonicate was 4.6% of that noted with intact cells. Addition of the NADPH-regenerating system resulted in a 13-fold increase in activity (Table IV) .
Effects of addition of increasing concentrations of NADPH on 12-HETE w-hydroxylation by a neutrophil microsomal fraction (see below) are depicted in Fig. 3 . NADPH (0.1-5,000 MM) was incubated with microsomes (192 ,ug of protein) and 17.6 ,uM 12-HETE for 15 min (37°C) in the presence ofthe NADPHregenerating system. Low levels of activity were present in the absence of exogenous NADPH, possibly owing to intrinsic residual neutrophil NADPH. However, at a level of2.5 MM added NADPH, a plateau ofactivity, 33-fold greater than that observed with no added cofactor, was achieved. Further increases of NADPH to concentrations of 5,000 MM did not enhance 12- HETE w-hydroxylation.
Subcellular localization of12-HETE w-hydroxylase activity. DFP-pretreated neutrophils were sonicated and subcellular fractions were prepared by standard differential ultracentrifugation techniques. The 10,000-g pellet was quantitatively enriched in $-glucuronidase, a granule marker enzyme. In three separate experiments mean values (± standard deviation), expressed as micrograms ofphenolphthalein released per hour per milligram of protein, were 361 (± 156) for the 10,000-g pellet (granules), 124 (±67) for the 100,000-g pellet (microsomes), and 16 (± 1) for the 100,000-g supernatant (soluble protein fraction). Assays Fig. 4 . Increasing quantities of 12-HETE were incubated with neutrophil microsomes (350 or 410 ,ug of protein) for 15 min (370C). The NADPH regenerating system (1 mM NADPH) was included. Apparent Km and V., values were determined from Lineweaver-Burk plots of the data and averaged 9.7MM and 0.4 nmol/min * mg ofprotein, respectively, in two separate experiments. Fig. 5 demonstrates the effect of pH on the 12-HETE whydroxylating activity of the neutrophil microsomal fraction. Optimal activity occurred in the range ofpH 7.3-7.5. A decrease in activity to 59% of maximum was noted at pH 7.0 and to 72% atpH 8.1.
A definite peak at 450 nm, indicative of cytochrome P-450 (21) was present in the carbon monoxide (dithionite-reduced vs. dithionite-reduced) difference spectrum of the neutrophil microsomal fraction (16) (Fig. 6 ). The cytochrome P.450 pealk became obvious after attenuation (by addition of dithionite to the reference cuvette) ofthe large peak representing cytochrome b (426 nm) in the carbon monoxide (dithionite-reduced vs. oxidized) difference spectrum. The CO (dithionite-reduced vs. dithionite-reduced) difference spectrum ofthe granule fraction (not shown), exhibited a trough rather than a peak at 450 nm.
w-Hydroxylation of12-HETE in the presence ofLTB4. LTB4
is the major eicosanoid synthesized by the stimulated neutrophil. indicated that the levels of exogenous LTB4 employed did not activate the neutrophil 5-lipoxygenase.
Discussion
Significant quantities ofplatelet-produced 12-HETE can be processed by neutrophils (8, 9) , which are known components of hemostatic platelet plugs and thrombi (31) . Unstimulated neutrophils convert 12-HETE from stimulated platelets to 12,20-DiHETE. Our data demonstrate that this occurs via a cytochrome P450 w-hydroxylation mechanism. Stimulated platelets can synthesize 12-HETE in abundance (17) . This synthesis is unabated after aspirin ingestion as measured in washed platelets . Difference spectra of the CO complex of reduced cytochrome P-450 in neutrophil microsomes. 1 ml of microsomal fraction suspension (1.45 mg of protein) was placed in sample and reference cuvettes. A baseline difference spectrum, recorded after bubbling the sample cuvette with CO, has been subtracted from the curves shown. Subsequent addition of sodium dithionite to the sample cuvette produced a CO (dithionite-reduced vs. oxidized) difference spectrum (dashed line). Addition of sodium dithionite to the reference cuvette as well, resulted in a CO (dithionite-reduced vs. dithionite-reduced) difference spectrum (solid line). and, as recently reported (32), is only partially and reversibly inhibited by aspirin in platelet-rich plasma as stimulated by collagen (20 ,gg/ml). Therefore it is important to understand regulation of further metabolism of 1 2-HETE. It has been known for some time that eicosanoids are metabolized to w-oxidation products in vivo (33) and in vitro (13) . In tissues such as liver and kidney, the hydroxylation is carried out by typical cytochrome P-450 monooxygenase systems (13) . One ofthe criteria commonly used for characterizing cytochrome P450 type mechanisms is the action of compounds known to inhibit these enzyme activities. As shown in Table I , an inhibitory effect on 12,20-DiHETE formation from 12-HETE by neutrophils was observed with all "classical" cytochrome P-450 inhibitors studied. Of particular pertinence was a-naphthoflavone which resulted in almost total inhibition in intact neutrophils and in microsomal fractions therefrom. Scavengers ofsuperoxide radicals and hydrogen peroxide, SOD and catalase respectively, had no effect on 12-HETE co-hydroxylation.
Carbon monoxide interacts with the ferrous ion ofthe heme moiety of cytochrome P-450 (34). The complex can be reversibly dissociated by reoxygenation. In our experiments, co-hydroxylation of platelet by neutrophils demonstrated this characteristic property of cytochrome P-450 enzymes. Thus, carbon monoxide exposure of the neutrophil resulted in 94% inhibition of 12,20-DiHETE formation from platelet (Table II) . This inhibition was completely reversible when the neutrophils were reoxygenated.
In contrast to cytochrome P450 enzyme systems in tissues such as kidney (30) and liver (35) In an attempt to prepare sonicates and subcellular fractions that were enzymatically active with respect to 12-HETE, neutrophils were sonicated in the presence of aI-antitrypsin or other protease inhibitors such as phenylmethylsulfonylfluoride (PMSF) . However, these sonicates also proved to be inactive. Sonicates capable of metabolizing 12-HETE could only be prepared in the presence of the protease inhibitor DFP, which permeated intact cells and granules and exerted its effect prior to granule disruption (23) . It was therefore concluded that neutrophil 12-HETE co-hydroxylating activity was very sensitive to proteolysis. Protease interference with w-hydroxylation in tissue homogenates was also observed in rat small intestine: microsomes washed with PMSF demonstrated significant w-hydroxylating activity, whereas untreated homogenates did not (13) . In our experiments no protective effect was observed with PMSF whether added before or after homogenization. With DFP-pretreated neutrophil homogenates or isolated microsomes, it was possible to demonstrate a definite requirement for NADPH as an electron donor (Table IV, Fig. 3 ). This is another identifying characteristic of cytochrome P-450 hydroxylase systems.
After establishing that 12-HETE w-hydroxylating activity in neutrophil homogenates could only be preserved by DFP pretreatment, it was possible to carry out subcellular localization experiments. As can be seen in Table V , the capacity to convert 12-HETE to 12,20-DiHETE was localized solely to the neutrophil microsomal fraction. Activity was undetectable in the granule or soluble subcellular compartments. Presence ofW-hydroxylating activity in neutrophil microsomes correlates with cytochrome P-450 localization in other tissues. It is important to mention that "microsomal fractions" as currently isolated contain both plasma membranes and intracellular membranes. As yet it is not known which of these membrane components actually contains the 12-HETE w-hydroxylase. The neutrophil enzyme we have studied may actually be located at or close to the cell surface and thereby be susceptible to degradation by proteases in the surrounding medium, as observed in this study. Further evidence for possible proximity to the cell surface is that the enzyme seems to be readily available to externally provided lipid substrate and that the product of the enzymatic reaction is found almost exclusively in the cell supernatant (9) . Another explanation for the inhibitory effect of neutrophil homogenates on intact cells is that conformational changes induced by proteolysis at the cell surface might affect components of the enzyme system, resulting in inactivation.
The carbon monoxide difference spectra of the microsomes we studied, demonstrated that 12-HETE co-hydroxylating activity was associated with a subcellular fraction containing a cytochrome P-450. This was in sharp contrast to the f3-glucuronidaseenriched granule fraction. The latter did not convert 12-HETE to 12,20-DiHETE and in fact exhibited a trough rather than a peak at 450 nm in the carbon monoxide difference spectrum.
There is accumulating evidence that cytochrome P-450 systems exist in multiple forms and possess varying substrate specificities (13, 36) . Recently, involvement of cytochrome P-450 enzymes in eicosanoid metabolism of cells participating in hemostasis and thrombosis has been demonstrated (37) . Thus platelet thromboxane and aortic microsomal prostacyclin synthases as well as neutrophil LTB4 co-hydroxylase have been characterized as cytochrome P450 enzymes (16, 37) . Several lines of evidence suggest the possibility that, as previously discussed (9) , the neutrophil LTB4 w-hydroxylase and the 12-HETE ohydroxylase described here may be similar or identical enzymes. LTB4 strongly inhibited conversion of 12-HETE to 12,20-DiHETE by isolated neutrophils (Fig. 7) . As evidenced by the total absence of 5,12-DiHETE production at all concentrations of LTB4 studied, the inhibition of 12,20-DiHETE formation was not due to diversion of 12-HETE to 5,12-DiHETE by LTB4 activation of neutrophil 5-lipoxygenase (8, 9) . Thus, in all likelihood LTB4 functioned as a competitive inhibitor of 12,20-DiHETE formation. The neutrophil 12-HETE w-hydroxylase and the LTB4 w-hydroxylase display maximal activity at similar pH ranges and require low concentrations of NADPH as a cofactor (16) . The Km ofthe 12-HETE w-hydroxylase for 12-HETE was 9.7 as compared with values reported for the w-hydroxylation of LTB4 by the neutrophil LTB4 w-hydroxylase of 0.6 (16) for a microsomal preparation, 0.22 (15) for a cytosolic preparation, and 1.0 (12) for intact neutrophils.
If the hydroxylating enzymes are indeed identical, the apparent higher affinity for LTB4 does not alter the significance of the cell-cell interaction with platelet 12-HETE described here. This reaction has occurred with neutrophils from every donor studied thus far. In situations wherein platelets have been stimulated by thrombin or collagen, neutrophils remain unstimulated and LTB4 is not formed (9) . In such instances, platelet 12-HETE would be the substrate of prime importance.
In our experiments neutrophil w-hydroxylation of 12-HETE in both intact cells and microsomal preparations was strongly inhibited by a-naphthoflavone (Table I, Fig. 2 ). This is in contrast to the neutrophil LTB4 w-hydroxylase which is not affected by this cytochrome P-450 inhibitor (16) . This is significant because a-naphthoflavone, the most potent nonsteroidal inhibitor ofhuman aromatase cytochrome P-450, exerts inhibitory selectivity toward hepatic P-450 isoenzymes (38) . The contrasting responses of the 12-HETE w-hydroxylase and the LTB4 w-hydroxylase to a-naphthoflavone inhibition remain to be resolved.
To summarize: 12-HETE is the proinflammatory monohydroxy lipoxygenase product of arachidonic acid, synthesized by stimulated platelets in the presence or absence of aspirin. Properties of the enzyme system in unstimulated neutrophils responsible for 12-HETE metabolism to 12,20-DiHETE have been defined. The enzyme activity involved in this cell-cell interaction was classified as a cytochrome P-450 as indicated by inhibitor studies, NADPH dependence, and subcellular microsomal localization. Neutrophil perturbation by any means inhibited w-hydroxylation of 12-HETE and this was prevented by the proteolytic enzyme inhibitor DFP. Induction or inhibition ofthe neutrophil cytochrome P-450 monooxygenase may eventually represent a possible therapeutic approach to modulation of platelet 12-HETE levels in vivo.
